Previous research has consistently identified the Ki-67 proliferation index as a critical prognostic marker in adrenocortical carcinoma (ACC), with thresholds of 10–20% linked to increased recurrence and reduced survival [8,9,11,14,39]. Here, MKI67 is linked to adrenal cortex carcinoma.